Leebeek, F. W. G. Et Al. 2023. Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial. European Journal of Haematology , vol.111, no.1 , 29-40.

Leebeek, F. W. G., Peyvandi, F., Tiede, A., Castaman, G., Escobar, M., Wang, M., ... ZÜLFİKAR, O. B.(2023). Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial. European Journal of Haematology , vol.111, no.1, 29-40.

Leebeek, Frank Et Al. "Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial," European Journal of Haematology , vol.111, no.1, 29-40, 2023

Leebeek, Frank W. Et Al. "Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial." European Journal of Haematology , vol.111, no.1, pp.29-40, 2023

Leebeek, F. W. G. Et Al. (2023) . "Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial." European Journal of Haematology , vol.111, no.1, pp.29-40.

@article{article, author={Frank W. G. Leebeek Et Al. }, title={Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial}, journal={European Journal of Haematology}, year=2023, pages={29-40} }